Malignant Otitis Externa
Also known as: Necrotising otitis externa
Invasive osteomyelitis of the temporal bone and skull base originating in the external auditory canal. The term malignant reflects the historically high mortality rather than neoplasia. Necrotising otitis externa is the more accurate designation.
Host factors
- Elderly diabetics account for the large majority. Microangiopathy of canal skin, impaired neutrophil chemotaxis and phagocytosis, and a higher cerumen pH combine to permit invasion.
- HIV infection, haematological malignancy, chemotherapy, transplantation and long term corticosteroids produce the disease at younger ages and often with normal glucose.
- Frequently precipitated by aural irrigation or instrumentation in a diabetic patient.
Microbiology
- Pseudomonas aeruginosa in more than 90 percent of bacterial cases, using elastase, alkaline protease and exotoxin A to invade cartilage and bone.
- Staphylococcus aureus, Proteus, Klebsiella and Burkholderia in a minority.
- Aspergillus fumigatus in the profoundly immunosuppressed, characteristically presenting with cranial neuropathy earlier and with less canal granulation.
Route of spread and the anatomy that explains the deficits
Infection passes through the fissures of Santorini and the bony cartilaginous junction into the retromandibular and parotid tissue, then along the skull base.
- Stylomastoid foramen: facial nerve palsy, the earliest and commonest cranial deficit, occurring in roughly 20 to 30 percent.
- Jugular foramen: glossopharyngeal, vagus and accessory involvement with dysphonia, dysphagia and shoulder weakness.
- Hypoglossal canal: tongue deviation.
- Petrous apex: trigeminal and abducens involvement.
- Further spread produces sigmoid sinus thrombosis, meningitis, temporal lobe abscess and, rarely, carotid erosion.
Mortality was historically around 50 percent and is now approximately 10 to 20 percent with antipseudomonal therapy, rising substantially once multiple cranial neuropathies or intracranial extension appear.

